Capecitabine and Paclitaxel in Treating Patients With Metastatic Breast Cancer

NCT00031876 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

34

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: capecitabine
DRUG: paclitaxel

Sponsor

Swiss Cancer Institute